Januptin

  • #
    medicine name: Januptin
  • #
    Generic name: Sitagliptin
  • #
    Medication Shape: Oral tablets
  • #
    Packing: Januptin 25: Box of 5 blisters of 10 scored F.C.tablets - Januptin 50: Box of 5 blisters of 10 scored F.C.tablets - Januptin 100: Box of 3 blisters of 10 scored F.C.tablets
  • #
    Pharmaceutical group: Diabetes

Indications:

Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Method of Use:

Adults: Usual: 100mg qd. 
Renal Insufficiency: Moderate (CrCl ≥30-<50mL/min): 50mg qd. 
Severe (CrCl <30mL/min)/End-Stage Renal Disease Requiring Hemodialysis or Peritoneal Dialysis: 25mg qd. With Insulin/Insulin Secretagogue (eg, Sulfonylurea): May require lower dose of insulin secretagogue or insulin.

prohibited usage:

Known hypersensitivity to the active substance, or any of the excipients.